Meds & supplements › Oxaliplatin
Medicine · Platinum-based Drug
Oxaliplatin Injection, in combination with infusional fluorouracil and leucovorin, is indicated for: adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor.
Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗
Oxaliplatin injection, in combination with infusional fluorouracil and leucovorin, is indicated for:
The following clinically significant adverse reactions are described elsewhere in labeling:
Oxaliplatin is contraindicated in patients with a history of a hypersensitivity reaction to oxaliplatin or other platinum-based drugs. Reactions have included anaphylaxis.
sofidex [Internet]. Daloreum; c2026. Oxaliplatin; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/oxaliplatin
sofidex. (2026, August 3). Oxaliplatin. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/oxaliplatin
Oxaliplatin. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/oxaliplatin
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.